000-51598 | 77-0259335 | |
(Commission File Number) | (IRS Employer Identification No.) | |
8 Crosby Drive, Bedford, Massachusetts | 01730 | |
(Address of Principal Executive Offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
Ex-99.1 Press Release issued by the registrant on February 11, 2009 |
99.1
|
Press Release issued by the registrant on February 11, 2009, furnished herewith. |
iRobot Corporation |
||||
February 11, 2009 | By: | /s/ Glen D. Weinstein | ||
Name: | Glen D. Weinstein | |||
Title: | General Counsel and Secretary |
Exhibit Number | Description | |
99.1
|
Press Release issued by the registrant on February 11, 2009, furnished herewith. |
Contacts: |
||
Elise Caffrey
|
Nancy Smith | |
Investor Relations
|
Media Relations | |
iRobot Corp.
|
iRobot Corp. | |
(781) 430-3003
|
(781) 430-3323 | |
ecaffrey@irobot.com
|
nsmith@irobot.com |
| Government & Industrial division delivered record revenue of $42.6 million in the fourth quarter of 2008, a 69 percent increase over the fourth quarter of 2007. | |
| International home robot revenue in the fourth quarter of 2008 was more than double the level of the fourth quarter of 2007 and comprised almost half of total home robot revenue in the quarter. Overall home robot revenue grew 20 percent for the full year. | |
| In the fourth quarter, the company received commitments for $5.7 million in funding for its Warrior robot. In 2009, iRobot has announced orders totaling $13 million for robots and spare parts under its $286 million xBot contract bringing total orders to date to $80 million. | |
| The company completed the integration of Nekton Research, LLC, which was acquired on September 8, 2008. |
Fiscal Year 2009: | ||
Revenue
|
$290 $310 million | |
Adjusted EBITDA
|
$14 $17 million | |
Earnings Per Share
|
$0.00 $0.04 |
Q1 2009: | ||
Revenue
|
$50 $55 million | |
Adjusted EBITDA Loss
|
($6) ($4) million | |
Loss Per Share
|
($0.18) ($0.12) |
For the three months ended | For the twelve months ended | |||||||||||||||
December 27, | December 29, | December 27, | December 29, | |||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
(unaudited) | (audited) | |||||||||||||||
Revenue |
||||||||||||||||
Product revenue |
$ | 82,712 | $ | 93,308 | $ | 281,187 | $ | 227,457 | ||||||||
Contract revenue |
7,990 | 5,432 | 26,434 | 21,624 | ||||||||||||
Total |
90,702 | 98,740 | 307,621 | 249,081 | ||||||||||||
Cost of Revenue |
||||||||||||||||
Product revenue |
51,302 | 57,779 | 190,250 | 147,689 | ||||||||||||
Contract revenue |
6,687 | 4,827 | 23,900 | 18,805 | ||||||||||||
Total |
57,989 | 62,606 | 214,150 | 166,494 | ||||||||||||
Gross Margin |
32,713 | 36,134 | 93,471 | 82,587 | ||||||||||||
Operating Expense |
||||||||||||||||
Research & development |
3,935 | 4,008 | 17,566 | 17,082 | ||||||||||||
Selling & marketing |
11,415 | 14,786 | 46,866 | 44,894 | ||||||||||||
General & administrative |
7,144 | 4,045 | 28,840 | 20,919 | ||||||||||||
Litigation & related expenses |
| 1,677 | | 2,341 | ||||||||||||
Total |
22,494 | 24,516 | 93,272 | 85,236 | ||||||||||||
Operating (loss) income |
10,219 | 11,618 | 199 | (2,649 | ) | |||||||||||
Other income, net |
9 | 488 | 926 | 3,151 | ||||||||||||
Pre-tax income |
10,228 | 12,106 | 1,125 | 502 | ||||||||||||
Income tax expense (benefit) |
4,806 | (8,609 | ) | 369 | (8,558 | ) | ||||||||||
Net income |
$ | 5,422 | $ | 20,715 | $ | 756 | $ | 9,060 | ||||||||
Net income per common share: |
||||||||||||||||
Basic |
$ | 0.22 | $ | 0.85 | $ | 0.03 | $ | 0.37 | ||||||||
Diluted |
$ | 0.21 | $ | 0.81 | $ | 0.03 | $ | 0.36 | ||||||||
Shares used in Per Common Share Calculations: |
||||||||||||||||
Basic |
24,775 | 24,448 | 24,654 | 24,229 | ||||||||||||
Diluted |
25,451 | 25,519 | 25,533 | 25,501 | ||||||||||||
Stock-based compensation included in above figures: |
||||||||||||||||
Cost of product revenue |
$ | 199 | $ | 171 | $ | 753 | $ | 692 | ||||||||
Cost of contract revenue |
162 | 94 | 462 | 386 | ||||||||||||
Research & development |
133 | 125 | 359 | 377 | ||||||||||||
Selling & marketing |
322 | 241 | 1,055 | 1,074 | ||||||||||||
General & administrative |
815 | 665 | 3,310 | 2,182 | ||||||||||||
Total |
$ | 1,631 | $ | 1,296 | $ | 5,939 | $ | 4,711 | ||||||||
December 27, | December 29, | |||||||
2008 | 2007 | |||||||
Assets |
||||||||
Cash and equivalents |
$ | 40,852 | $ | 26,735 | ||||
Short term investments |
| 16,550 | ||||||
Accounts receivable, net |
35,930 | 47,681 | ||||||
Unbilled revenues |
2,014 | 2,244 | ||||||
Inventory, net |
34,560 | 45,222 | ||||||
Deferred tax assets |
7,299 | 5,905 | ||||||
Other current assets |
3,340 | 2,268 | ||||||
Total current assets |
123,995 | 146,605 | ||||||
Property, plant and equipment, net |
22,929 | 15,694 | ||||||
Deferred tax assets |
4,508 | 4,293 | ||||||
Other assets |
12,246 | 2,500 | ||||||
Total assets |
$ | 163,678 | $ | 169,092 | ||||
Liabilities and stockholders equity |
||||||||
Accounts payable |
$ | 19,544 | $ | 44,697 | ||||
Accrued expenses |
10,989 | 7,987 | ||||||
Accrued compensation |
6,393 | 4,603 | ||||||
Deferred revenue and customer advances |
2,632 | 1,578 | ||||||
Total current liabilities |
39,558 | 58,865 | ||||||
Long term liabilities |
4,444 | | ||||||
Stockholders equity |
119,676 | 110,227 | ||||||
Total liabilities and stockholders equity |
$ | 163,678 | $ | 169,092 | ||||
For the three months ended | For the twelve months ended | |||||||||||||||
December 27, | December 29, | December 27, | December 29, | |||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
(unaudited) | (audited) | |||||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net income |
$ | 5,422 | $ | 20,715 | $ | 756 | $ | 9,060 | ||||||||
Adjustments to reconcile net income to net cash
provided by (used in) operating activities: |
||||||||||||||||
Depreciation and amortization |
1,894 | 1,322 | 7,029 | 5,311 | ||||||||||||
Loss on disposal of fixed assets |
151 | | 231 | 48 | ||||||||||||
Stock-based compensation |
1,631 | 1,296 | 5,939 | 4,711 | ||||||||||||
In-process research and development relating to
acquisition of Nekton Research LLC |
| | 200 | | ||||||||||||
Benefit from deferred tax assets |
(1,967 | ) | (10,198 | ) | (1,967 | ) | (10,198 | ) | ||||||||
Non-cash director deferred compensation |
24 | 28 | 95 | 111 | ||||||||||||
Changes in working capital (use) source |
||||||||||||||||
Accounts receivable |
10,391 | (12,524 | ) | 12,221 | (19,171 | ) | ||||||||||
Unbilled revenue |
258 | 513 | 230 | (283 | ) | |||||||||||
Inventory |
8,036 | (1,511 | ) | 10,662 | (24,332 | ) | ||||||||||
Other assets |
5,888 | (229 | ) | (1,042 | ) | 595 | ||||||||||
Accounts payable |
(11,810 | ) | (1,251 | ) | (25,350 | ) | 17,012 | |||||||||
Accrued expenses |
1,597 | 2,886 | 3,002 | 967 | ||||||||||||
Accrued compensation |
(1,869 | ) | (2,985 | ) | 1,634 | (624 | ) | |||||||||
Deferred revenue |
(101 | ) | 438 | 1,026 | 1,121 | |||||||||||
Change in long term liabilities |
(108 | ) | | 4,444 | | |||||||||||
Net cash provided by (used in) operating activities |
19,437 | (1,500 | ) | 19,110 | (15,672 | ) | ||||||||||
Cash flows from investing activities: |
||||||||||||||||
Purchase of property and equipment |
(1,228 | ) | (3,896 | ) | (14,817 | ) | (10,352 | ) | ||||||||
Purchase of Nekton Research LLC, net of cash
received |
2 | | (9,743 | ) | | |||||||||||
Change in other assets |
| (2,500 | ) | | (2,500 | ) | ||||||||||
Purchases of investments |
| (8,200 | ) | (29,997 | ) | (52,950 | ) | |||||||||
Sales of investments |
16,197 | 17,950 | 46,547 | 101,200 | ||||||||||||
Net cash provided by (used in) investing activities |
14,971 | 3,354 | (8,010 | ) | 35,398 | |||||||||||
Cash flows from financing activities: |
||||||||||||||||
Borrowings under revolving credit line |
| | 5,500 | | ||||||||||||
Repayment of borrowings under revolving credit line |
(5,500 | ) | | (5,500 | ) | | ||||||||||
Income tax withholding payment associated with
stock option exercise |
| | | (1,588 | ) | |||||||||||
Proceeds from stock option exercises |
103 | 55 | 1,011 | 1,388 | ||||||||||||
Tax benefit of excess stock based compensation
deductions |
1,326 | 1,626 | 2,006 | 1,626 | ||||||||||||
Net cash provided by (used in) financing activities |
(4,071 | ) | 1,681 | 3,017 | 1,426 | |||||||||||
Net increase in cash and cash equivalents |
30,337 | 3,535 | 14,117 | 21,152 | ||||||||||||
Cash and cash equivalents, at beginning of period |
10,515 | 23,200 | 26,735 | 5,583 | ||||||||||||
Cash and cash equivalents, at end of period |
$ | 40,852 | $ | 26,735 | $ | 40,852 | $ | 26,735 | ||||||||
For the three months ended | For the twelve months ended | |||||||||||||||
December 27, | December 29, | December 27, | December 29, | |||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Revenue by business unit (in thousands): |
||||||||||||||||
Home Robots |
||||||||||||||||
Product |
$ | 48,123 | $ | 73,481 | $ | 173,547 | $ | 144,413 | ||||||||
Contract |
| 45 | 55 | 70 | ||||||||||||
Government & Industrial |
||||||||||||||||
Product |
34,589 | 19,827 | 107,640 | 83,044 | ||||||||||||
Contract |
7,990 | 5,387 | 26,379 | 21,554 | ||||||||||||
$ | 90,702 | $ | 98,740 | $ | 307,621 | $ | 249,081 | |||||||||
Direct Revenue Home Robots (in thousands) |
$ | 8,183 | $ | 13,314 | $ | 30,697 | $ | 33,770 | ||||||||
Product Lifecycle Revenue Government &
Industrial (in thousands) |
$ | 8,652 | $ | 6,180 | $ | 20,004 | $ | 20,668 | ||||||||
International Revenue (in thousands): |
||||||||||||||||
Home Robots |
$ | 23,159 | $ | 10,326 | $ | 65,942 | $ | 21,723 | ||||||||
Government & Industrial |
$ | 475 | $ | 3,057 | $ | 6,045 | $ | 10,923 | ||||||||
Average selling prices for robot units: |
||||||||||||||||
Home Robots |
$ | 150 | $ | 158 | $ | 150 | $ | 148 | ||||||||
Government & Industrial (in thousands) |
$ | 85 | $ | 126 | $ | 92 | $ | 132 | ||||||||
Gross Margin by business unit (in thousands): |
||||||||||||||||
Home Robots |
$ | 16,074 | $ | 26,636 | $ | 49,769 | $ | 46,605 | ||||||||
Government & Industrial |
16,639 | 9,498 | 43,702 | 35,982 | ||||||||||||
$ | 32,713 | $ | 36,134 | $ | 93,471 | $ | 82,587 | |||||||||
Units shipped by business unit: |
||||||||||||||||
Home Robots (in thousands) |
293 | 441 | 1,054 | 898 | ||||||||||||
Government & Industrial |
306 | 108 | 951 | 471 | ||||||||||||
Government & Industrial Funded Backlog (in
thousands) |
$ | 8,401 | $ | 26,095 | $ | 8,401 | $ | 26,095 | ||||||||
Days sales outstanding |
38 | 46 | 38 | 46 | ||||||||||||
Inventory turnover |
6.0 | 5.1 | 6.0 | 5.1 | ||||||||||||
Net cash
provided by (used in) operating activities (in
thousands) |
$ | 19,437 | $ | (1,500 | ) | $ | 19,110 | $ | (15,672 | ) | ||||||
Headcount |
479 | 423 | 479 | 423 |